Name: KalVista Pharmaceuticals, Inc. (KALV) Balance Sheet
Creator: FinSpry

KalVista Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for KalVista Pharmaceuticals, Inc. (KALV) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2025	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019
Current Assets
Cash and Cash Equivalents	98.64	31.79	56.24	30.73	248.93	67.71	100.81
Short-Term Investments	89.00	178.61	93.14	135.47	198.34	0.00	0.00
Cash & Short-Term Investments	187.65	210.40	149.38	166.20	248.93	67.71	100.81
Accounts Receivable	15.14	10.87	18.64	16.81	11.72	0.00	11.32
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	38.90	4.42	4.31	14.10	10.40	16.53	0.00
Total Current Assets	241.69	225.69	172.33	193.65	264.26	88.70	115.55
Non-Current Assets
Property, Plant & Equipment (Net)	1.99	9.15	10.77	10.04	7.55	3.66	2.41
Other Non-Current Assets	7.09	0.57	0.11	0.19	0.20	0.18	0.17
Total Non-Current Assets	9.08	9.71	10.88	10.23	7.75	3.83	2.59
Total Assets	250.77	235.40	183.20	203.88	272.01	92.53	118.13
Current Liabilities
Accounts Payable	4.88	9.11	4.82	3.64	8.91	7.13	6.56
Short-Term Debt	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	11.18	5.71	9.13	2.79	6.93	0.00	0.00
Deferred Revenue	11.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	27.31	6.69	4.21	4.17	3.51	2.33	0.00
Total Current Liabilities	45.17	22.81	15.03	11.58	9.77	7.72	18.05
Non-Current Liabilities
Long-Term Debt	4.33	6.02	7.15	7.21	5.05	1.06	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	110.21	6.02	7.15	7.21	5.05	1.06	3.34
Total Liabilities	155.38	28.82	22.18	18.79	14.82	8.78	21.39
Stockholders' Equity
Common Stock	0.05	0.04	0.03	0.03	0.02	0.00	0.00
Retained Earnings	-653.17	-469.73	-343.08	-250.18	-169.27	-123.47	-92.48
Accumulated Other Comprehensive Income	-5.21	-3.49	-3.06	-3.86	-1.43	0.00	-1.93
Additional Paid-in Capital	753.73	679.75	507.13	439.10	426.44	207.21	191.12
Shares Outstanding	49.76	42.52	34.17	24.55	0.00	0.00	0.00
Total Stockholders' Equity	95.39	206.58	161.03	185.09	257.19	83.75	96.74
Total Liabilities & Equity	250.77	235.40	183.23	203.88	272.01	92.53	118.13